0001209191-19-020034.txt : 20190318
0001209191-19-020034.hdr.sgml : 20190318
20190318170346
ACCESSION NUMBER: 0001209191-19-020034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190314
FILED AS OF DATE: 20190318
DATE AS OF CHANGE: 20190318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evans David Thomas
CENTRAL INDEX KEY: 0001730451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 19689039
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-14
0
0001666071
Cardlytics, Inc.
CDLX
0001730451
Evans David Thomas
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
0
1
0
0
Chief Financial Officer
Common Stock
2019-03-14
4
S
0
884
15.32
D
49619
D
Common Stock
2019-03-15
4
S
0
879
15.39
D
48740
D
Common Stock
2019-03-18
4
S
0
871
15.54
D
47869
D
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.
The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.30 to $15.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.34 to $15.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.54 to $15.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Kirk L. Somers, Attorney-in-Fact
2019-03-18